Summarily, in AML patients, the abnormally elevated level of TNF-α secreted by CD4+ T especially Th17 cells promoted the higher Tregs frequency via the TNF-α–TNFR2 pathway. This evidence concerns the gene TNFRSF1B and acute myeloid leukemia.